Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
11,193,182
-
Share change
-
+372,419
-
Total reported value
-
$316,693,904
-
Put/Call ratio
-
0%
-
Price per share
-
$28.32
-
Number of holders
-
88
-
Value change
-
+$7,878,399
-
Number of buys
-
48
-
Number of sells
-
29
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2017
As of 31 Dec 2017,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,193,182 shares.
The largest 10 holders included
CPMG Inc, BlackRock Inc., FMR LLC, Vanguard Group Inc, EMERALD ADVISERS INC/PA, Laurion Capital Management LP, EMERALD MUTUAL FUND ADVISERS TRUST, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FRANKLIN RESOURCES INC, and PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.